Community/Retail

The life of a typical pharmacy student isn't easy.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, offers tips for how pharmacists can monitor for hypoglycemia in type 2 diabetics on second-line therapies.

Pharmacists should keep an eye out for patients with diabetes taking pravastatin and paroxetine concomitantly, as this medication combination could be deadly.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the obstacles that pharmacists are encountering as naloxone access continues to improve.

OptumRx and Walgreens are partnering to create a new pharmacy solution to meet consumers' changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings.

Patients celebrating St. Patrick’s Day while taking medications affected by alcohol are going to have a bad time.

The reversal agent for rocuronium (Zemuron) is creating big buzz among emergency departments and anesthesia suites.

Dennis Williams, PharmD, FAPhA, talks about ways to prevent allergies related to pets and dust.

After finding glass particulate in a vial, Teva Pharmaceuticals is recalling 1 lot of its amikacin sulfate injection USP, 1 gram/4 mL, vials.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, outlines some strategies for pharmacists tasked with selecting the most appropriate second-line therapy for their patients with type 2 diabetes.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses what comorbid conditions to look out for among asthma and COPD patients.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the challenges that pharmacists face when treating behavioral health conditions.

Sneha Srivastava, PharmD, BCACP, discusses how pharmacists can work toward improving outcomes for patients recently discharged after heart failure.

Sneha Srivastava, PharmD, BCACP, discusses the new and emerging therapies to treat heart failure.

Now in its eighth year, the 2016 National Association of Chain Drug Stores RxIMPACT Day on Capitol Hill kicked off today by showcasing both quantity and quality in grassroots advocacy and political engagement.

The National Association of Chain Drug Stores has announced the expansion of its get-out-the-vote initiative for 2016, with new video ads to encourage pharmacy personnel to volunteer and vote for the candidates of their choice.

It seems as though many great innovations have stemmed from unplanned findings.

Experts around the world recently assembled at the 5th American Cough Conference to discuss the latest findings in cough care.

Pharmacy-driven education can increase immunization acceptance among hospitalized patients refusing flu or pneumococcal vaccination upon admission.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses whether or not allowing pharmacists to dispense naloxone without a prescription can help reduce fatal outcomes.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses how pharmacists can combat the stigmas associated with mental illness.

When a woman's 4-week-old infant stopped breathing in a shopping center, the first place she thought to take her baby was the nearby pharmacy, where 2 staff members quickly went to work resuscitating the child.

The CVS Health Foundation, has announced the second round of grants awarded in partnership with the Campaign for Tobacco-Free Kids through the "Making the Next Generation Tobacco-Free" grant program.

The Leukemia & Lymphoma Society and Walgreens have announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers.

Kroger has announced the promotion of Mary Ellen Adcock to serve as the company's group vice president of retail operations, effective May 16.

Obese patients who are able to lose 5% of their bodyweight may lower their risk for type 2 diabetes.

Dan Steiber, editor in chief for Specialty Pharmacy Times, speaks to True North P.S. President Ron Lanton.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses what therapeutic options are available for managing asthma and chronic obstructive pulmonary disorder.

The FDA has approved Teva's generic version of sildenafil citrate.

The emergence of new oral anticoagulants presents pharmacists with an opportunity to intervene in assisting patients with selecting the most appropriate drug therapy.